PubMed HealthSearch

Biomedical subjects

G C Moses

Publications and source records attributed to G C Moses.

15 recordsLinked to original sources

Effectiveness of noise in blocking electromagnetic effects on enzyme activity in the chick embryo.

We have previously demonstrated that exposure of the chick embryo to a 60 Hz, 4 microT split sine wave for the first 72 hours of development causes a significant reduction in the activity of the ectoenzyme 5'-nucleotidase. This reduced activity persisted, throughout the embryonic period, despite further incubation in a field free environment. We also showed that the reduction in 5'NT activity can be localized in the developing brain to the Cerebellum. The present study reveals that superimposition of an electromagnetic noise, of similar amplitude and frequency, can mitigate the effect of the field on 5'NT activity.

5'-Nucleotidase

Examination of the development of chicken embryos following exposure to magnetic fields.

1. Studies of effects produced by magnetic fields on developing chickens have been reviewed. 2. Compilations of the variety of field conditions utilized, and of the consequences of the tested conditions on the embryo, are reported in tabular form for comparison. 3. The developmental consequences, if any, of the fields are also reported, as are those aspects of timing and morphogenesis deemed important in this area. 4. More recent information on biochemical changes in embryos exposed to magnetic fields is included and given weight as a growing aspect of this scientific field of study.

Animals

Effects of extremely low-frequency electromagnetic fields on three plasma membrane-associated enzymes in early chicken embryos.

Exposure to a 60 Hz, 4 uT electromagnetic field caused significant changes in levels of 5'nucleotidase (5'NT), acetylcholinesterase (AChE) and alkaline phosphatase (ALP) during early embryonic development in the chicken. Enzyme levels were significantly higher in embryos with various forms of anatomic malformations (abnormal) than in those with no visible abnormal characteristics (normal). The presence of the electromagnetic field was associated with a marked reduction in enzyme activities in abnormal embryos. Overall mean specific activities for 5'NT, AChE and ALP were 12, 57, 67 and 38, 196, 111 nmol/min/mg protein in abnormal-exposed versus abnormal-control embryos, respectively. In normal-exposed versus normal-control embryos, the values were 5, 28, 57 and 10, 29, 58, respectively.

5'-Nucleotidase

Use of purified lyophilized human lactate dehydrogenase isoenzyme 5 in a study of measuring lactate dehydrogenase activity.

We examined the stability of human lactate dehydrogenase (EC 1.1.1.27) isoenzyme 5--purified to a specific activity of about 400 kU/g--when lyophilized in a buffered, stabilized matrix of bovine albumin. This isoenzyme was prepared with a final activity of about 500 U/L and stored at -20, 4, 20, 37, and 56 degrees C for as long as six months. This isoenzyme decayed with approximate first-order kinetics, with an estimated half-life at -20 degrees C of about 475 years. Stability of reconstituted samples stored at 20 or 4 degrees C was poor, suggesting that the reconstituted material should be used without delay; material stored at -20 degrees C showed excellent stability for 15 days. We propose that such preparations might be further investigated as standards for use in electrophoresis of lactate dehydrogenase isoenzymes.

Enzyme Stability

Ten electrophoretic methods compared with a selected method for quantifying lactate dehydrogenase isoenzymes in serum.

Using the Selected Method of McKenzie and Henderson (Selected Methods Clin Chem 1983;10:59-67) as a reference method, we compared the performance of 10 commercially available methods for determination of lactate dehydrogenase (LD, EC 1.1.1.27) isoenzymes. Results were expressed as percentage of total LD activity, as determined with two different types of densitometers shown to have an average difference less than 1.4% for each isoenzyme. All methods gave generally comparable results, as judged by Bland-Altman plots and correlation analyses. However, in general, estimates by the commercial methods for LD-1, LD-2, and LD-3 were lower, and for LD-4 and LD-5 were higher than with the Selected Method. The overall CV was less than 20% for all methods and isoenzymes, except for LD-4 and LD-5 by the Beckman Paragon, Helena LD-VIS, Gel LDH, Gel PC, and Iso Dot, Gelman LDH Isozyme, and Sebia Hydragel assays, for which it was greater than 20%. Overall, accuracy was best with the Helena Iso Dot and LD-VIS assays, followed by the Corning LD Flur assay; accuracy was poorest with the Gelman LDH Isozyme, Sebia Hydragel, and Beckman Paragon assays.

Electrophoresis

A clinical evaluation of the Cobas Fara clinical chemistry analyzer for some routine serum enzymes and glucose.

The authors evaluated the Cobas FARA centrifugal analyzer with respect to pipetting precision and accuracy, instrument temperature, spectrophotometric response, and analytic performance for the assay of five serum enzymes and glucose. Spectrophotometric response, temperature response, pipetting precision, and accuracy were satisfactory. However, sufficient time must be allowed for cuvet contents to reach a stable temperature before measurements are made. Total day-to-day imprecision (within plus between run) was less than 5% (coefficient of variation) for aspartate and alanine aminotransferases (AST; Enzyme Commission classification number [EC] EC 2.6.1.1; and ALT; EC 2.6.1.2); alkaline phosphatase (AP; EC 3.1.3.1); gamma-glutamyltransferase (GGT; EC 2.3.1.2); lactate dehydrogenase (LD; EC 1.1.1.17); creatine kinase (CK; EC 2.7.3.1); and glucose assays. Results compare well with those obtained with other current clinical chemistry analyzers; correlation coefficients were greater than 0.993. Sample-to-sample carryover was negligible, and method linearity was satisfactory for all tests.

Blood Chemical Analysis

Increased serum lactate dehydrogenase isoenzyme 1 and "flipped" LD-1/LD-2 ratio in myopathy associated with partial carnitine palmitoyltransferase deficiency.

We describe a case of a limb-girdle myopathy presenting with myoglobinuria. A partial deficiency of muscle carnitine palmitoyltransferase (EC 2.3.1.21) may also have been present. All "muscle-type" serum enzymes were markedly increased (to between 30- and 400-fold their respective upper reference limits) and creatine kinase (EC 2.7.3.2) isoenzyme 2 (CK-MB) was increased 130-fold but was still less than 2% of the total creatine kinase activity. The isoenzyme pattern of lactate dehydrogenase (EC 1.1.1.27) in serum was "anodic," with isoenzyme 1 greater than isoenzyme 2--an unusual pattern for myopathies. The possible physiological basis for such a finding is discussed.

Acyltransferases

Biological variance of cholinesterase and 5'-nucleotidase in serum of healthy persons.

We measured cholinesterase (EC 3.1.1.8) and 5'-nucleotidase (EC 3.1.3.5) activities in serum of 24 healthy laboratory staff during 12 months. Overall mean activities ranged from 5.3 to 13.4 kU/L for cholinesterase and 5.4 to 9.8 U/L for 5'-nucleotidase. Cholinesterase activity was significantly (p less than 0.01) higher for men than for women. 5'-Nucleotidase activity was significantly (p = 0.01) higher for subjects 40 years or older than for those younger than 40, but was not different with respect to sex or time of year. Average intra- and interindividual variances (SD2) were 0.38 and 2.69 for cholinesterase and 1.41 and 0.97 for 5'-nucleotidase, respectively. Intra- to interindividual standard deviation ratios were 0.38 for cholinesterase and 1.21 for 5'-nucleotidase. Average within-run analytical variances were 0.13 and 0.3 (4% and 13% of total variance) for cholinesterase and 5'-nucleotidase, respectively. The importance of these findings in regards to diagnostic interpretation of serum cholinesterase and 5'-nucleotidase results is discussed.

5'-Nucleotidase

Use of purified lyophilized human lactate dehydrogenase isoenzymes in a study of the measurement of lactate dehydrogenase activity.

We examined the stability of human lactate dehydrogenase (EC 1.1.1.27; LD) isoenzymes 1, 2, and 3--purified to specific activities of about 200 kU/g--when lyophilized in a buffered stabilized matrix of bovine albumin. Each isoenzyme was prepared at two activity concentrations and stored at -20, 4, 20, 37, and 56 degrees C for as long as six months. LD-1 activity decayed with zero-order kinetics, LD-2 and LD-3 with first-order kinetics. The extrapolated half-lives of these preparations at -20 degrees C varied between 80 and 530 years. Stability of reconstituted samples stored at 4 degrees C was excellent for LD-1 but poor for LD-2 and LD-3. We suggest that preparations of human LD-1 be further investigated as a possible reference material.

Freeze Drying

The EPOS Automated Selective Chemistry Analyzer evaluated.

We evaluated the analytical performance of the EPOS (Eppendorf Patient Oriented System) Automated Selective Chemistry Analyzer, using the following tests for serum analytes: alanine and aspartate aminotransferases, lactate dehydrogenase, creatine kinase, gamma-glutamyltransferase, alkaline phosphatase, and glucose. Results from the EPOS correlated well with those from comparison instruments (r greater than or equal to 0.990). Precision and linearity limits were excellent for all tests; linearity of the optical and pipetting systems was satisfactory. Reagent carryover was negligible. Sample-to-sample carryover was less than 1% for all tests, but only lactate dehydrogenase was less than the manufacturer's specified 0.5%. Volumes aspirated and dispensed by the sample and reagent II pipetting systems differed significantly from preset values, especially at lower settings; the reagent I system was satisfactory at all volumes tested. Minimal daily maintenance and an external data-reduction system make the EPOS a practical alternative to other bench-top chemistry analyzers.

Adult

Routine "cardiac" and "hepatic" serum enzyme profiles in cardiac-transplant patients treated with cyclosporine A: operative and post-operative findings.

We report representative serum enzyme changes after cardiac transplantation in 20 patients receiving post-transplant therapy with cyclosporine. In general, the changes resembled those after acute myocardial infarction or coronary artery bypass surgery, but were more prolonged. Cardiac biopsy or episodes of cardiac rejection did not usually alter serum enzyme activities. Cyclosporine A toxicity appeared to be responsible for increases in serum transaminases (alanine and aspartate) and lactate dehydrogenase-5 activities. Serum gamma-glutamyltransferase activities were intermittently, and inexplicably, increased for months after the transplant.

Adolescent

Biological variance of total lactate dehydrogenase and its isoenzymes in human serum.

We measured the variance components of total lactate dehydrogenase (LD; EC 1.1.1.27) activity and isoenzymes in sera of 24 healthy laboratory staff, ages 23-50 years, over a 12-month period. We used the first six weeks' results to establish baseline values for each analyte in each individual. These values were "normally" distributed for total LD and isoenzymes 1 through 4, but values for isoenzyme-5 were skewed slightly to the left. The overall means and variances determined for the remaining 10 months were not significantly (p greater than 0.05) different from the corresponding baseline values. Average variances (SD2) for the longer-term (10-month) study were: intra-individual, 732, 1.92, 2.25, 1.09, 1.11, and 2.25, and inter-individual, 1988, 5.03, 1.76, 1.57, 1.21, and 2.01 for total LD (U/L) and LD-1 through LD-5 (% of total), respectively. Average long-term analytical variability was less than 35% of the total variance for the five isoenzymes and 6% for total LD, and was characteristic of the individual. There were no significant differences in mean activities with respect to age or sex. All six analytes exhibited slight seasonal variations.

Adult

Purification of lactate dehydrogenase isoenzymes one, two, and three from human erythrocytes.

Lactate dehydrogenase (LD) isoenzymes 1, 2, and 3 were prepared from human erythrocytes by sequential ion-exchange chromatography followed by general-ligand (AMP analog) affinity chromatography. Respective yields, purification factors, and specific activities (kU per gram of protein) were 25%, 4394-fold, and 209.7; 40% 4385-fold, and 199.1; and 18%, 7565-fold, and 192.9. The respective preparations contained less than 0.5% of contaminating LD isoenzyme activity as judged from electrophoresis on thin-layer agarose, were homogeneous as judged by electrophoresis on polyacrylamide gel (both in the presence and absence of sodium lauryl sulfate), and showed minor contamination by other LD isoenzymes as judged by analytical isoelectric focusing. We think that these preparations would be useful as human-based calibrating or reference materials. Their purity is such that these preparations could also be used as antigens for the development of suitable antisera.

Chromatography, Affinity

Continuous-flow analysis of ammonia in perchloric acid supernate of blood or plasma using an ammonia-selective electrode.

A simple automated method for the estimation of ammonia in perchloric acid supernate of blood or plasma using an ion-selective electrode (Orion Ammonia-selective electrode, Model 95-10) is described. The reliability of the proposed method has been checked against an ion-exchange resin procedure, which has been chosen as a standard procedure. Regression equation and correlation coefficient for the proposed method are y = 0.7 X + 10 and 0.945, respectively, as compared with the chosen standard method. Within-run and between-run precision are 2.1% and 3.5% respectively. The average percent recovery is 97.5% and a tentative range is 13-73 microgram/dl (9-52 micronmol/l) ammonia nitrogen.

Adult